To see this page, please, enable javaScript and styleSheets on your browser: Tools -> Internet Options ...
Reload !
Gene BCCIPTABLE OF CONTENTS / OPEN CLOSE ALL PARAGRAPHS
Summary back to top
Compact gene diagram back to top
576 supporting clones for gene BCCIP back to top
cDNA accession
Links to the sequence
Tissue

most 5' clones
in red
Match
mRNA
From bp
to bp
in mRNA
From bp
to bp
in accs.
Clone encodes
complete protein
(with AA variation)
Features Anomalies
detected by
AceView
Accession
match over
(% length)
Base differences
relative to genome
(% identity)
BG704917 brain, hippocampus .a 1 to 654 1 to 654   tiling clone,   654/654
(100 %)
6 diff
(99.1 %id)
BM905542 embryonal carcinoma, cell line, testis .a 12 to 813 19 to 823       805/1034
(77 %)
10 diff
(99.1 %id)
AY064248   .a 16 to 1344 1 to 1329 exact     1329/1329
(100 %)
1 diff
(100.0 %id)
BG436272 placenta .a 16 to 623 1 to 621       621/731
(84 %)
32 diff
(95.7 %id)
NM_016567.3   .a 16 to 1458 1 to 1443 exact RefSeq, AAA Possibly primed on the genome, locally A rich (19/21 A in genome downstream of last aligned base) 1443/1443
(100 %)
0 diff
(100 %id)
CD710086 normal nasopharynx .a 19 to 260 18 to 258       241/258
(93 %)
6 diff
(97.7 %id)
DA473848   .a 19 to 452 132 to 565   capped   434/564
(76 %)
5 diff
(99.2 %id)
BG723406 testis .a 19 to 768 8 to 761       754/761
(99 %)
22 diff
(97.2 %id)
FN142016 breast carcinoma .a 20 to 100 1 to 80       80/85
(94 %)
6 diff
(93.0 %id)
BX502656 Liver .a 21 to 543 1 to 523       523/523
(100 %)
2 diff
(99.7 %id)
BU940966 mixed (pool of 40 RNAs) .a 21 to 704 1 to 687       687/793
(86 %)
8 diff
(99.0 %id)
CD687927 normal nasopharynx .a 22 to 363 27 to 369       343/374
(91 %)
13 diff
(96.6 %id)
CD690820 normal nasopharynx .a 22 to 471 16 to 464       449/464
(96 %)
6 diff
(98.8 %id)
CD691559 normal nasopharynx .a 22 to 648 25 to 651       627/651
(96 %)
7 diff
(99.0 %id)
CD692921 normal nasopharynx .a 22 to 406 16 to 400       385/400
(96 %)
6 diff
(98.5 %id)
BU657912 blood .a 22 to 445 5 to 428       424/428
(99 %)
7 diff
(98.4 %id)
BU659129 blood .a 22 to 500 4 to 482       479/482
(99 %)
7 diff
(98.6 %id)
BU664751 blood .a 22 to 505 5 to 488       484/488
(99 %)
7 diff
(98.6 %id)
BI562442 testis .a 22 to 813 1 to 801       801/813
(98 %)
19 diff
(97.7 %id)
BG536870 lung .a 23 to 731 1 to 705       705/705
(100 %)
6 diff
(99.2 %id)
BG718304 testis .a 24 to 797 1 to 772       772/772
(100 %)
7 diff
(99.1 %id)
BG771826 testis .a 24 to 477 1 to 454       454/456
(99 %)
4 diff
(99.2 %id)
BI561455 testis .a 24 to 813 1 to 791       791/811
(97 %)
16 diff
(98.1 %id)
BU502227 mixed (pool of 40 RNAs) .a 24 to 568 1 to 552       552/996
(55 %)
29 diff
(97.1 %id)
BU933806 mixed (pool of 40 RNAs) .a 24 to 805 1 to 791       791/818
(96 %)
23 diff
(97.2 %id)
BU945455 mixed (pool of 40 RNAs) .a 24 to 813 1 to 797       797/809
(98 %)
17 diff
(97.9 %id)
TI_44350673   .a 24 to 813 84 to 874       791/894
(88 %)
20 diff
(97.8 %id)
DA022192   .a 25 to 592 2 to 569   capped   568/568
(100 %)
0 diff
(100 %id)
DA616259   .a 25 to 501 2 to 479   capped   478/478
(100 %)
2 diff
(99.6 %id)
CB853849 lung, Primary Lung Epithelial Cells .a 25 to 804 1 to 776     Submitted on the opposite strand 776/777
(99 %)
10 diff
(98.8 %id)
BX646395   .a 26 to 639 1 to 614       614/614
(100 %)
2 diff
(99.7 %id)
BF669443 brain, primitive neuroectoderm .a 26 to 642 1 to 611       611/877
(69 %)
19 diff
(97.9 %id)
BU927607 mixed (pool of 40 RNAs) .a 26 to 387 1 to 363       363/431
(84 %)
7 diff
(98.4 %id)
BU941496 mixed (pool of 40 RNAs) .a 26 to 828 1 to 801       799/802
(99 %)
14 diff
(98.3 %id)
BU941557 mixed (pool of 40 RNAs) .a 26 to 643 1 to 614       614/670
(91 %)
12 diff
(98.3 %id)
BU954282 mixed (pool of 40 RNAs) .a 26 to 727 1 to 703       703/704
(99 %)
7 diff
(99.1 %id)
BU959556 mixed (pool of 40 RNAs) .a 26 to 465 1 to 441       441/469
(94 %)
9 diff
(98.1 %id)
AA089951   .a 27 to 158 1 to 132       132/135
(97 %)
2 diff
(98.6 %id)
AB040450 brain .a 27 to 1285 1 to 1259 exact AAA Possibly primed on the genome, locally A rich (19/21 A in genome downstream of last aligned base) 1259/1260
(99 %)
6 diff
(99.6 %id)
AL703394 human skeletal muscle .a 27 to 628 1 to 602       602/602
(100 %)
2 diff
(99.7 %id)
DA528160 brain .a 27 to 574 2 to 549   capped   548/548
(100 %)
1 diff
(99.9 %id)
BP873073 embryonal kidney .a 27 to 608 1 to 582       582/582
(100 %)
0 diff
(100 %id)
BI458846 testis .a 27 to 634 1 to 596       567/600
(94 %)
32 diff
(94.7 %id)
BQ277158 mixed (pool of 40 RNAs) .a 27 to 527 1 to 504       504/1272
(39 %)
10 diff
(99.3 %id)
TI_44350833   .a 27 to 813 132 to 927       796/939
(84 %)
21 diff
(97.8 %id)
TI_1540413430   .a 27 to 325 301 to 3       299/337
(88 %)
0 diff
(100 %id)
TI_1540413618   .a 27 to 310 301 to 18       284/316
(89 %)
0 diff
(100 %id)
DA001917   .a 28 to 574 2 to 548   capped   547/547
(100 %)
0 diff
(100 %id)
BG944661 blood .a 28 to 405 1 to 378       378/378
(100 %)
2 diff
(99.5 %id)
DA164200 amygdala .a 28 to 592 2 to 566   capped   565/565
(100 %)
0 diff
(100 %id)
DA383936 thalamus .a 28 to 598 2 to 572   capped   571/571
(100 %)
0 diff
(100 %id)
BX482608   .a 28 to 641 1 to 614       614/614
(100 %)
1 diff
(99.9 %id)
AL697866 human skeletal muscle .a 28 to 733 1 to 715       715/720
(99 %)
11 diff
(98.5 %id)
BX645112   .a 28 to 601 1 to 574       574/574
(100 %)
2 diff
(99.7 %id)
DA503825 brain .a 28 to 587 2 to 562   capped   561/561
(100 %)
1 diff
(99.9 %id)
DA521776 brain .a 28 to 593 2 to 567   capped   566/566
(100 %)
0 diff
(100 %id)
DA534656 heart .a 28 to 574 2 to 549   capped   548/548
(100 %)
1 diff
(99.9 %id)
BF240496 bone marrow, from acute myelogenous leukemia .a 28 to 652 1 to 622       622/882
(70 %)
17 diff
(98.1 %id)
BG527963 lung, mucoepidermoid carcinoma .a 28 to 635 1 to 612       612/881
(69 %)
9 diff
(99.0 %id)
BG527939 lung, mucoepidermoid carcinoma .a 28 to 634 1 to 613       613/749
(81 %)
8 diff
(99.0 %id)
DA606290   .a 28 to 572 2 to 546   capped   545/545
(100 %)
0 diff
(100 %id)
DA609844   .a 28 to 574 2 to 548   capped   547/547
(100 %)
2 diff
(99.7 %id)
DA617658   .a 28 to 602 2 to 576   capped   575/575
(100 %)
0 diff
(100 %id)
DA820934 pericardium .a 28 to 584 2 to 558   capped   557/557
(100 %)
0 diff
(100 %id)
DA847115 placenta .a 28 to 571 2 to 545   capped   544/544
(100 %)
0 diff
(100 %id)
DA928171 small intestine .a 28 to 597 2 to 571   capped   570/570
(100 %)
0 diff
(100 %id)
DA958715 Spleen .a 28 to 584 2 to 558   capped   557/557
(100 %)
0 diff
(100 %id)
DB049189 testis .a 28 to 584 2 to 558   capped   557/557
(100 %)
0 diff
(100 %id)
DB126615 thymus .a 28 to 563 2 to 537   capped   536/536
(100 %)
0 diff
(100 %id)
DB173231 kidney, tumor tissue .a 28 to 419 2 to 393   capped   392/392
(100 %)
0 diff
(100 %id)
DB250725 uterus .a 28 to 602 2 to 576   capped   575/575
(100 %)
0 diff
(100 %id)
CD705032 normal nasopharynx .a 29 to 257 16 to 244       229/244
(93 %)
7 diff
(97.2 %id)
FN124840 breast carcinoma .a 29 to 113 86 to 1     Submitted on the opposite strand 86/87
(98 %)
1 diff
(98.9 %id)
FN167127 breast carcinoma .a 29 to 113 1 to 82       82/85
(96 %)
6 diff
(93.0 %id)
DB443381 testis .a 29 to 283 1 to 255       255/255
(100 %)
5 diff
(98.1 %id)
DB459851 testis .a 29 to 185 1 to 157       157/192
(81 %)
2 diff
(99.0 %id)
CB989747 Human Placenta, placenta .a 29 to 769 28 to 772       745/791
(94 %)
13 diff
(98.4 %id)
BM847297 myeloma .a 29 to 628 1 to 598       598/598
(100 %)
2 diff
(99.7 %id)
TI_1540413524   .a 29 to 311 300 to 18       283/335
(84 %)
1 diff
(99.8 %id)
DA066988 cerebellum .a 30 to 602 2 to 574   capped   573/573
(100 %)
1 diff
(99.9 %id)
DA085589 cerebellum .a 30 to 603 2 to 575   capped   574/574
(100 %)
0 diff
(100 %id)
DA167726 amygdala .a 30 to 597 2 to 569   capped   568/568
(100 %)
0 diff
(100 %id)
DA172304 amygdala .a 30 to 574 2 to 547   capped   546/546
(100 %)
1 diff
(99.9 %id)
DA276180 corpus callosum .a 30 to 602 2 to 575   capped   574/579
(99 %)
3 diff
(99.5 %id)
DA474629   .a 30 to 598 2 to 570   capped   569/569
(100 %)
1 diff
(99.9 %id)
BF245646 brain, glioblastoma .a 30 to 641 1 to 613       613/846
(72 %)
15 diff
(98.3 %id)
BG431307 Kidney .a 30 to 504 1 to 475       475/475
(100 %)
2 diff
(99.6 %id)
CD103436 Pooled-Skin .a 30 to 610 1 to 588       588/833
(70 %)
18 diff
(97.9 %id)
CD643351 Embryonic Stem cells .a 30 to 812 1 to 773       773/834
(92 %)
21 diff
(97.5 %id)
DA650625   .a 30 to 580 2 to 552   capped   551/551
(100 %)
0 diff
(100 %id)
DA693569   .a 30 to 610 2 to 581   capped   580/580
(100 %)
1 diff
(99.9 %id)
DA707216   .a 30 to 601 2 to 576   capped   575/575
(100 %)
3 diff
(99.5 %id)
DN995132 brain, whole brain .a 30 to 742 1 to 712       712/712
(100 %)
7 diff
(99.1 %id)
DB130288 thymus .a 30 to 597 2 to 569   capped   568/568
(100 %)
0 diff
(100 %id)
DB175561 kidney, tumor tissue .a 30 to 596 2 to 569   capped   568/568
(100 %)
1 diff
(99.9 %id)
DA354441 substantia nigra .a 31 to 597 2 to 568   capped   567/567
(100 %)
0 diff
(100 %id)
CR616411 B cells (Ramos cell line) Cot 25-normalized .a 31 to 1226 1 to 1196 exact     1196/1196
(100 %)
0 diff
(100 %id)
BX401806   .a 31 to 843 1 to 813   fully sequenced,   813/813
(100 %)
1 diff
(99.9 %id)
DA868853 Prostate .a 31 to 572 2 to 542   capped   541/541
(100 %)
1 diff
(99.9 %id)
TI_149272977   .a 31 to 895 51 to 906     Submitted on the opposite strand 856/911
(93 %)
22 diff
(97.6 %id)
BF215920 brain, glioblastoma .a 32 to 652 1 to 617       617/894
(69 %)
22 diff
(97.6 %id)
BG540527 lung .a 32 to 711 1 to 690       690/872
(79 %)
29 diff
(96.7 %id)
BG818983 anaplastic oligodendroglioma with 1p/19qloss, brain .a 32 to 748 20 to 739       720/740
(97 %)
12 diff
(98.4 %id)
CB215255 normal endometrium, late proliferativephase, cycle day 13, uterus .a 32 to 664 1 to 633       633/633
(100 %)
0 diff
(100 %id)
CN364342 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .a 33 to 660 1 to 629       629/629
(100 %)
1 diff
(99.9 %id)
N98390 lung .a 33 to 304 1 to 278       273/281
(97 %)
10 diff
(96.5 %id)
CN364352 embryonic stem cells, DMSO-treated H9 cellline .a 34 to 720 1 to 687       687/687
(100 %)
8 diff
(98.9 %id)
BX443737 T cells (Jurkat cell line) .a 34 to 764 1 to 731       731/731
(100 %)
0 diff
(100 %id)
BI855888 breast, mammary adenocarcinoma, cell line .a 34 to 808 1 to 783       783/899
(87 %)
8 diff
(99.2 %id)
DB109798 thymus .a 34 to 623 2 to 591   capped   590/590
(100 %)
0 diff
(100 %id)
DA956905 Spleen .a 35 to 589 2 to 557   capped   556/556
(100 %)
1 diff
(99.9 %id)
CN364345 embryonic stem cells, cell lines H1, H7, andH9 .a 36 to 739 1 to 704       704/704
(100 %)
2 diff
(99.8 %id)
L48818 retinal fovea .a 36 to 256 1 to 221       221/221
(100 %)
7 diff
(96.9 %id)
BQ433350 large cell carcinoma, lung .a 36 to 822 36 to 825       790/893
(88 %)
22 diff
(97.6 %id)
CX785265 human embryonic stem cells .a 36 to 815 1 to 780       780/780
(100 %)
1 diff
(99.9 %id)
DR760633 embryonic stem .a 36 to 799 1 to 764       764/764
(100 %)
1 diff
(99.9 %id)
DA584469 lung .a 37 to 604 2 to 570   capped   569/570
(99 %)
2 diff
(99.7 %id)
CX784369 human embryonic stem cells .a 37 to 820 10 to 793       784/793
(98 %)
8 diff
(99.0 %id)
CX754045 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .a 37 to 731 1 to 693       693/897
(77 %)
7 diff
(99.3 %id)
DA749390   .a 37 to 594 2 to 559   capped   558/558
(100 %)
0 diff
(100 %id)
DA904936   .a 37 to 593 2 to 558   capped   557/557
(100 %)
0 diff
(100 %id)
DA923485 small intestine .a 37 to 602 2 to 567   capped   566/566
(100 %)
0 diff
(100 %id)
DB017501 esophageal, tumor tissue .a 37 to 607 2 to 572   capped   571/571
(100 %)
0 diff
(100 %id)
DB249881 uterus .a 37 to 589 2 to 555   capped   554/554
(100 %)
1 diff
(99.9 %id)
DB264849 uterus .a 37 to 607 2 to 573   capped   572/572
(100 %)
1 diff
(99.9 %id)
BG828774 muscle, rhabdomyosarcoma .a 38 to 677 1 to 661       628/667
(94 %)
31 diff
(95.4 %id)
BI225528 Burkitt lymphoma, lymph .a 38 to 450 1 to 418       418/482
(86 %)
16 diff
(96.7 %id)
CX872797 embryonic stem .a 38 to 812 1 to 775       775/776
(99 %)
1 diff
(99.9 %id)
TI_1948091299   .a 38 to 626 142 to 730       589/1360
(43 %)
20 diff
(98.6 %id)
TI_1948091411   .a 38 to 722 141 to 829       689/1367
(50 %)
31 diff
(97.8 %id)
AA319043 adrenal gland .a 39 to 249 1 to 211       211/214
(98 %)
2 diff
(99.1 %id)
CN364353 embryonic stem cells, DMSO-treated H9 cellline .a 39 to 625 1 to 586       586/586
(100 %)
1 diff
(99.9 %id)
CN364354 embryonic stem cells, cell lines H1, H7, andH9 .a 39 to 646 19 to 625       607/625
(97 %)
6 diff
(99.1 %id)
CR590039 fetal liver .a 39 to 1431 1 to 1393 exact tiling clone,   1393/1393
(100 %)
0 diff
(100 %id)
AL531223 brain, fetal liver, Liver, neuroblastoma cells .a 39 to 668 1 to 630   fully sequenced,   630/630
(100 %)
0 diff
(100 %id)
CV028045 mixed .a 39 to 630 1 to 592       592/592
(100 %)
0 diff
(100 %id)
AW961499   .a 40 to 574 1 to 534       534/538
(99 %)
26 diff
(95.2 %id)
CN364346 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .a 41 to 519 1 to 479       479/479
(100 %)
0 diff
(100 %id)
BE397809 Burkitt lymphoma, lymph .a 41 to 743 29 to 742       712/743
(95 %)
20 diff
(97.4 %id)
BG752571 eye, normal pigmented retinal epithelium .a 41 to 666 1 to 626       626/626
(100 %)
1 diff
(99.9 %id)
BG752586 eye, normal pigmented retinal epithelium .a 41 to 628 1 to 587       587/587
(100 %)
1 diff
(99.9 %id)
CX761555 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .a 41 to 769 1 to 729     Submitted on the opposite strand 729/729
(100 %)
4 diff
(99.5 %id)
TI_57167255   .a 41 to 767 27 to 753       727/753
(96 %)
6 diff
(99.3 %id)
AA094694   .a 42 to 160 1 to 119       119/124
(95 %)
6 diff
(95.2 %id)
BX101041 multiple sclerosis lesions .a 42 to 698 1 to 657       657/668
(98 %)
1 diff
(99.9 %id)
BM451256 eye, retinoblastoma .a 42 to 450 1 to 409       409/1051
(38 %)
6 diff
(99.5 %id)
BM541437 leiomyosarcoma, uterus .a 42 to 633 1 to 604       604/1309
(46 %)
33 diff
(97.5 %id)
CD557434 testis .a 42 to 886 1 to 855       855/905
(94 %)
14 diff
(98.5 %id)
BG473486 eye, retinoblastoma .a 43 to 623 1 to 597       595/775
(76 %)
30 diff
(96.2 %id)
CN364349 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .a 44 to 778 1 to 735       735/735
(100 %)
0 diff
(100 %id)
CN364350 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .a 44 to 673 1 to 630       630/630
(100 %)
1 diff
(99.9 %id)
AA360655   .a 45 to 300 1 to 256       256/256
(100 %)
2 diff
(99.3 %id)
AV648448 corresponding non cancerous liver tissue .a 45 to 738 1 to 692     Submitted on the opposite strand 692/696
(99 %)
4 diff
(99.5 %id)
AV648455 corresponding non cancerous liver tissue .a 45 to 761 1 to 716     Submitted on the opposite strand 716/716
(100 %)
22 diff
(97.0 %id)
N47351 multiple sclerosis lesions .a 45 to 352 1 to 307       307/307
(100 %)
5 diff
(98.4 %id)
BI835520 pooled pancreas and spleen .a 45 to 767 1 to 723       723/723
(100 %)
2 diff
(99.8 %id)
BQ958129 carcinoma, cell line, Prostate .a 45 to 822 1 to 780       780/968
(80 %)
13 diff
(98.7 %id)
AA305139 colon .a 46 to 470 1 to 425       425/425
(100 %)
0 diff
(100 %id)
AA330453   .a 46 to 362 1 to 317       317/317
(100 %)
0 diff
(100 %id)
CX756376 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .a 46 to 750 1 to 704     Submitted on the opposite strand 704/706
(99 %)
3 diff
(99.6 %id)
BX378563 Placenta Cot 25-normalized .a 47 to 642 1 to 594       594/714
(83 %)
19 diff
(97.4 %id)
CN364348 embryonic stem cells, DMSO-treated H9 cellline .a 49 to 450 1 to 402       402/409
(98 %)
5 diff
(98.8 %id)
CN364351 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .a 49 to 775 1 to 725       725/725
(100 %)
4 diff
(99.5 %id)
CN364347 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .a 50 to 412 1 to 363       363/363
(100 %)
0 diff
(100 %id)
BU170450 eye, retinoblastoma .a 52 to 894 1 to 850       850/911
(93 %)
11 diff
(98.8 %id)
CB270440 adipose .a 53 to 770 1 to 718       718/718
(100 %)
8 diff
(98.9 %id)
DA295352 hippocampus .a 55 to 639 2 to 586   capped   585/585
(100 %)
0 diff
(100 %id)
BM048484 carcinoma, cell line, Prostate .a 55 to 798 1 to 760       760/763
(99 %)
45 diff
(94.2 %id)
AA376308 lung .a 56 to 359 1 to 304       304/311
(97 %)
1 diff
(99.7 %id)
BF981934 duodenal adenocarcinoma, cell line, small intestine .a 56 to 719 22 to 683       662/683
(96 %)
9 diff
(98.7 %id)
BM559496 amelanotic melanoma, cell line, skin .a 56 to 805 1 to 798       798/951
(83 %)
12 diff
(98.8 %id)
BE734138 choriocarcinoma, placenta .a 58 to 811 1 to 757       757/942
(80 %)
13 diff
(98.7 %id)
CD579776 brain .a 58 to 687 13 to 642       630/643
(97 %)
14 diff
(97.9 %id)
BE890839 melanotic melanoma, skin .a 59 to 536 1 to 482       482/482
(100 %)
4 diff
(99.2 %id)
BF694231 muscle (skeletal) .a 61 to 720 1 to 656       656/656
(100 %)
13 diff
(98.1 %id)
BQ650549 hepatocellular carcinoma, cell line, Liver .a 61 to 895 10 to 845       836/993
(84 %)
12 diff
(98.8 %id)
BU662726 blood .a 62 to 650 1 to 589       589/589
(100 %)
0 diff
(100 %id)
BE546569 cervical carcinoma cell line, cervix .a 62 to 786 1 to 712       712/921
(77 %)
16 diff
(98.3 %id)
BF852844 lung_normal .a 63 to 554 496 to 5     Submitted on the opposite strand 492/496
(99 %)
13 diff
(97.4 %id)
BE733039 choriocarcinoma, placenta .a 63 to 801 1 to 736       736/902
(81 %)
9 diff
(99.1 %id)
BQ329356 lung_normal .a 65 to 560 1 to 494       494/507
(97 %)
19 diff
(96.3 %id)
BF208030 bladder, carcinoma, cell line .a 65 to 605 1 to 540       540/540
(100 %)
2 diff
(99.7 %id)
AA382609 testis .a 67 to 283 1 to 217       217/239
(90 %)
6 diff
(97.5 %id)
BE541717 cervix .a 69 to 742 1 to 670       670/670
(100 %)
6 diff
(99.2 %id)
BE881628 large cell carcinoma, undifferentiated, lung .a 71 to 725 1 to 658       658/1056
(62 %)
7 diff
(99.4 %id)
BQ638877 eye, retina .a 73 to 687 1 to 615       615/615
(100 %)
0 diff
(100 %id)
BI869669 adenocarcinoma, cell line, Liver .a 73 to 813 1 to 742       742/870
(85 %)
15 diff
(98.3 %id)
TI_57228966   .a 73 to 813 90 to 831       742/870
(85 %)
15 diff
(98.3 %id)
CN364356 embryonic stem cells, DMSO-treated H9 cellline .a 74 to 596 1 to 524       524/524
(100 %)
1 diff
(99.9 %id)
BE893236 melanotic melanoma, skin .a 74 to 795 1 to 729       729/778
(93 %)
16 diff
(98.0 %id)
BQ216342 large cell carcinoma, lung .a 75 to 893 1 to 824       824/889
(92 %)
19 diff
(97.9 %id)
CR982301 T-Lymphocytes .a 98 to 800 1 to 704       704/704
(100 %)
1 diff
(99.9 %id)
BI048344 stomach .a 100 to 309 1 to 213       211/213
(99 %)
12 diff
(94.4 %id)
AA204809   .a 131 to 363 1 to 233       233/235
(99 %)
7 diff
(97.1 %id)
CN364340 embryonic stem cells, DMSO-treated H9 cellline .a 140 to 346 1 to 207       207/207
(100 %)
0 diff
(100 %id)
BF989381 placenta_normal .a 161 to 533 389 to 19       371/390
(95 %)
4 diff
(99.0 %id)
FN143932 breast carcinoma .a 165 to 240 1 to 75       75/78
(96 %)
4 diff
(94.9 %id)
AA135383 colon, tumor .a 173 to 437 1 to 266       266/270
(98 %)
2 diff
(99.3 %id)
BM785385 stomach .a 176 to 784 1 to 610       610/610
(100 %)
1 diff
(99.9 %id)
D82374   .a 178 to 461 1 to 284       284/284
(100 %)
1 diff
(99.7 %id)
D82507   .a 179 to 521 1 to 343       343/343
(100 %)
3 diff
(99.2 %id)
BF244628 brain, glioblastoma .a 185 to 768 1 to 581       581/846
(68 %)
11 diff
(98.7 %id)
BX446465 placenta .a 192 to 812 124 to 748       625/748
(83 %)
53 diff
(93.0 %id)
BX438388 neuroblastoma .a 193 to 892 148 to 844       697/847
(82 %)
26 diff
(97.0 %id)
BI335515 cervical carcinoma cell line, cervix .a 193 to 669 168 to 645       478/645
(74 %)
13 diff
(98.0 %id)
BF212555 bone marrow, from chronic myelogenous leukemia .a 195 to 889 1 to 685       685/869
(78 %)
22 diff
(97.5 %id)
AA226439   .a 196 to 504 406 to 97       310/406
(76 %)
1 diff
(99.8 %id)
DB177525 kidney, tumor tissue .a 196 to 748 2 to 554   capped   553/555
(99 %)
2 diff
(99.7 %id)
BQ306936 breast .a 202 to 724 532 to 13       520/557
(93 %)
24 diff
(95.7 %id)
BM685783 eye, Retina Foveal and Macular .a 202 to 812 9 to 612     Possibly primed on the genome, locally A rich (19/21 A in genome downstream of last aligned base) 604/612
(98 %)
12 diff
(98.1 %id)
FN162370 breast carcinoma .a 214 to 314 101 to 1     Submitted on the opposite strand 101/101
(100 %)
0 diff
(100 %id)
CB134459 Liver .a 214 to 746 1 to 533       533/533
(100 %)
0 diff
(100 %id)
BU657073 blood .a 230 to 488 1 to 259       259/259
(100 %)
0 diff
(100 %id)
AA036797.
matches multiple genes
uterus .a 237 to 512 1 to 282     also hits gene ICAM2 282/282
(100 %)
11 diff
(96.1 %id)
BU664788 blood .a 245 to 591 1 to 347       347/347
(100 %)
1 diff
(99.8 %id)
FN117183 breast carcinoma .a 254 to 355 101 to 1     Submitted on the opposite strand 101/101
(100 %)
1 diff
(99.1 %id)
BX956732   .a 262 to 739 1 to 478       478/478
(100 %)
0 diff
(100 %id)
BM699242 eye, fetal eyes .a 277 to 630 1 to 354   fully sequenced, Possibly primed on the genome, locally A rich (19/21 A in genome downstream of last aligned base) 354/354
(100 %)
0 diff
(100 %id)
BM698933 eye, fetal eyes .a 279 to 753 1 to 474   fully sequenced, Possibly primed on the genome, locally A rich (19/21 A in genome downstream of last aligned base) 474/474
(100 %)
2 diff
(99.6 %id)
BP873193 embryonal kidney .a 282 to 863 1 to 582       582/582
(100 %)
1 diff
(99.9 %id)
CN364343 embryonic stem cells, DMSO-treated H9 cellline .a 294 to 813 1 to 521       521/525
(99 %)
7 diff
(98.7 %id)
FN046773 breast carcinoma .a 320 to 415 96 to 1     Submitted on the opposite strand 96/96
(100 %)
0 diff
(100 %id)
CB135545 Liver .a 323 to 722 1 to 400       400/400
(100 %)
0 diff
(100 %id)
BE798578 lung, small cell carcinoma .a 339 to 1195 40 to 884       845/938
(90 %)
27 diff
(97.2 %id)
T97397 liver and spleen .a 379 to 659 1 to 283       283/283
(100 %)
4 diff
(98.6 %id)
FN106906 breast carcinoma .a 382 to 492 111 to 1     Submitted on the opposite strand 111/111
(100 %)
0 diff
(100 %id)
BQ084443 stomach .a 435 to 791 1 to 357       357/357
(100 %)
0 diff
(100 %id)
FN123798 breast carcinoma .a 448 to 552 108 to 3     Submitted on the opposite strand 106/115
(92 %)
0 diff
(100 %id)
FN154351 breast carcinoma .a 448 to 549 100 to 1     Submitted on the opposite strand 100/109
(91 %)
3 diff
(97.3 %id)
BI856517 breast, mammary adenocarcinoma, cell line .a 450 to 1294 1 to 847       847/860
(98 %)
24 diff
(97.3 %id)
TI_57188460   .a 450 to 1294 57 to 904       848/904
(93 %)
23 diff
(97.5 %id)
TI_149307282   .a 450 to 1221 858 to 90   AAA Possibly primed on the genome, locally A rich (19/21 A in genome downstream of last aligned base) 769/980
(78 %)
9 diff
(99.1 %id)
TI_154110388   .a 450 to 1224 846 to 80   AAA Possibly primed on the genome, locally A rich (19/21 A in genome downstream of last aligned base) 767/919
(83 %)
12 diff
(98.7 %id)
TI_154130842   .a 450 to 1219 848 to 85   AAA Possibly primed on the genome, locally A rich (19/21 A in genome downstream of last aligned base) 764/963
(79 %)
7 diff
(99.3 %id)
EC467842 Prostate .a 458 to 567 1 to 108       108/108
(100 %)
6 diff
(94.5 %id)
EC497526 Prostate .a 460 to 568 1 to 110       110/110
(100 %)
1 diff
(99.1 %id)
FN135266 breast carcinoma .a 478 to 574 96 to 1     Submitted on the opposite strand 96/103
(93 %)
2 diff
(98.1 %id)
FN177214 breast carcinoma .a 479 to 584 104 to 1     Submitted on the opposite strand 104/104
(100 %)
3 diff
(97.2 %id)
BQ375730 testis_normal .a 493 to 904 412 to 1       412/412
(100 %)
2 diff
(99.6 %id)
FN108778 breast carcinoma .a 493 to 571 1 to 78       78/79
(98 %)
2 diff
(97.5 %id)
CA448124 Chondrosarcoma, Left Pubic Bone .a 498 to 1224 740 to 17   AAA Possibly primed on the genome, locally A rich (19/21 A in genome downstream of last aligned base) 724/724
(100 %)
3 diff
(99.6 %id)
BM979094 lung, Primary Lung Epithelial Cells .a 514 to 1221 724 to 17   AAA Possibly primed on the genome, locally A rich (19/21 A in genome downstream of last aligned base) 708/708
(100 %)
4 diff
(99.5 %id)
BM069737 Islets of Langerhans, Pancreas .a 515 to 967 1 to 455   fully sequenced, Possibly primed on the genome, locally A rich (19/21 A in genome downstream of last aligned base) 455/455
(100 %)
8 diff
(98.3 %id)
TI_149283983   .a 519 to 1221 785 to 86   AAA Possibly primed on the genome, locally A rich (19/21 A in genome downstream of last aligned base) 700/700
(100 %)
9 diff
(98.8 %id)
TI_149306477   .a 533 to 1285 847 to 100   AAA Possibly primed on the genome, locally A rich (19/21 A in genome downstream of last aligned base) 748/971
(77 %)
7 diff
(99.3 %id)
BP384078 pancreatic islet .a 540 to 967 427 to 1       427/427
(100 %)
1 diff
(99.8 %id)
CA417895 Bone, Human Chondrosarcoma Cell Line .a 570 to 1219 668 to 19   AAA Possibly primed on the genome, locally A rich (19/21 A in genome downstream of last aligned base) 650/650
(100 %)
0 diff
(100 %id)
AA524258 colon .a 578 to 1226 646 to 3       646/646
(100 %)
10 diff
(98.5 %id)
BU622241 Cell Line, Chondrosarcoma .a 578 to 1219 660 to 19   AAA Possibly primed on the genome, locally A rich (19/21 A in genome downstream of last aligned base) 642/642
(100 %)
0 diff
(100 %id)
EC535364 Prostate .a 584 to 658 1 to 76       76/85
(89 %)
3 diff
(96.5 %id)
EC444027 Prostate .a 586 to 679 94 to 2       93/94
(98 %)
0 diff
(100 %id)
AW970673   .a 588 to 1224 635 to 1     Submitted on the opposite strand 635/635
(100 %)
9 diff
(98.6 %id)
BU597686 mixed (pool of 40 RNAs) .a 594 to 1092 1 to 515   AAA   515/1014
(50 %)
25 diff
(97.6 %id)
BU686508 lung, Primary Lung Epithelial Cells .a 597 to 1285 708 to 19   AAA Possibly primed on the genome, locally A rich (19/21 A in genome downstream of last aligned base) 690/690
(100 %)
1 diff
(99.9 %id)
BM669901 eye, fetal eyes .a 600 to 1215 634 to 19   fully sequenced, AAA Possibly primed on the genome, locally A rich (19/21 A in genome downstream of last aligned base) 616/616
(100 %)
0 diff
(100 %id)
AL563988 brain, fetal liver, Liver, neuroblastoma cells .a 607 to 1431 821 to 1   fully sequenced,   821/821
(100 %)
6 diff
(99.3 %id)
CA422631 cell lines, Chondrosarcoma .a 617 to 1285 687 to 19   AAA Possibly primed on the genome, locally A rich (19/21 A in genome downstream of last aligned base) 669/669
(100 %)
0 diff
(100 %id)
TI_149292397   .a 634 to 1458 900 to 84   AAA Possibly primed on the genome, locally A rich (19/21 A in genome downstream of last aligned base) 817/922
(88 %)
14 diff
(98.5 %id)
BM984360 lung .a 635 to 1221 602 to 17   AAA Possibly primed on the genome, locally A rich (19/21 A in genome downstream of last aligned base) 586/595
(98 %)
4 diff
(99.4 %id)
TI_154060830   .a 640 to 1458 923 to 111   AAA Possibly primed on the genome, locally A rich (19/21 A in genome downstream of last aligned base) 813/958
(84 %)
10 diff
(99.0 %id)
CB157900 Liver .a 673 to 1013 1 to 341       341/341
(100 %)
0 diff
(100 %id)
EL953120 eyeball .a 681 to 1215 1 to 535   AAA Possibly primed on the genome, locally A rich (19/21 A in genome downstream of last aligned base) 535/535
(100 %)
3 diff
(99.5 %id)
BF592156 Kidney .a 681 to 1215 535 to 1       535/535
(100 %)
0 diff
(100 %id)
BM974496 lung .a 700 to 1458 776 to 19   AAA Possibly primed on the genome, locally A rich (19/21 A in genome downstream of last aligned base) 758/758
(100 %)
3 diff
(99.7 %id)
BU624375 cell lines, Enchondroma .a 715 to 1458 766 to 24   AAA Possibly primed on the genome, locally A rich (19/21 A in genome downstream of last aligned base) 743/746
(99 %)
6 diff
(99.2 %id)
CR595451 Neuroblastoma Cot 25-normalized .a 718 to 1459 1 to 742   tiling clone,   742/742
(100 %)
0 diff
(100 %id)
AL526364 brain, neuroblastoma cells, Neuroblastoma Cot 25-normalized .a 718 to 1459 1 to 742   fully sequenced,   742/742
(100 %)
1 diff
(99.9 %id)
TI_154103952   .a 718 to 1458 825 to 90   AAA Possibly primed on the genome, locally A rich (19/21 A in genome downstream of last aligned base) 736/906
(81 %)
9 diff
(99.1 %id)
AW007523 anaplastic oligodendroglioma, brain .a 722 to 1221 500 to 1       500/500
(100 %)
0 diff
(100 %id)
BM669720 eye, fetal eyes .a 723 to 1289 581 to 15   fully sequenced, AAA Possibly primed on the genome, locally A rich (19/21 A in genome downstream of last aligned base) 567/567
(100 %)
0 diff
(100 %id)
TI_151776923   .a 725 to 1221 69 to 564   AAA Possibly primed on the genome, locally A rich (19/21 A in genome downstream of last aligned base) 496/564
(87 %)
9 diff
(98.5 %id)
BM674173 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .a 726 to 1221 512 to 17   AAA Possibly primed on the genome, locally A rich (19/21 A in genome downstream of last aligned base) 496/504
(98 %)
7 diff
(98.7 %id)
CA943268 Pancreas, Purified pancreatic islet .a 727 to 1096 1 to 370   fully sequenced, Possibly primed on the genome, locally A rich (19/21 A in genome downstream of last aligned base) 370/370
(100 %)
6 diff
(98.4 %id)
BM794824 Ascites, stomach .a 727 to 1219 1 to 493   AAA Possibly primed on the genome, locally A rich (19/21 A in genome downstream of last aligned base) 493/493
(100 %)
0 diff
(100 %id)
AW235516 Kidney .a 735 to 1281 551 to 5       547/551
(99 %)
1 diff
(99.9 %id)
AI884643 anaplastic oligodendroglioma, brain .a 738 to 1290 553 to 1       553/553
(100 %)
1 diff
(99.9 %id)
BF514251   .a 752 to 1221 485 to 16   AAA Possibly primed on the genome, locally A rich (19/21 A in genome downstream of last aligned base) 470/470
(100 %)
1 diff
(99.8 %id)
BF001645 colon, colon tumor, RER+ .a 758 to 1220 463 to 1       463/463
(100 %)
0 diff
(100 %id)
AI884642 anaplastic oligodendroglioma, brain .a 760 to 1281 531 to 10       522/531
(98 %)
0 diff
(100 %id)
AW082697 pooled .a 761 to 1288 529 to 2       528/529
(99 %)
0 diff
(100 %id)
BE465727 Kidney .a 761 to 1225 465 to 1       465/465
(100 %)
0 diff
(100 %id)
AI150622 heart .a 763 to 1219 457 to 1       457/457
(100 %)
3 diff
(99.4 %id)
AI765464 2 pooled tumors (clear cell type), Kidney .a 763 to 1288 526 to 1       526/526
(100 %)
2 diff
(99.7 %id)
AW302230 Kidney .a 763 to 1220 460 to 3       458/460
(99 %)
1 diff
(99.8 %id)
AI765465 2 pooled tumors (clear cell type), Kidney .a 765 to 1288 524 to 1       524/528
(99 %)
0 diff
(100 %id)
CA446136 Chondrosarcoma, Left Pubic Bone .a 771 to 1458 704 to 19   AAA Possibly primed on the genome, locally A rich (19/21 A in genome downstream of last aligned base) 686/686
(100 %)
2 diff
(99.8 %id)
AI334975 2 pooled tumors (clear cell type), Kidney .a 775 to 1220 448 to 3       446/448
(99 %)
0 diff
(100 %id)
BX401805   .a 782 to 1226 445 to 1   fully sequenced,   445/445
(100 %)
9 diff
(98.0 %id)
DB525294 testis .a 795 to 1226 1 to 432     Submitted on the opposite strand 432/435
(99 %)
1 diff
(99.8 %id)
CA420218 Bone, Human Chondrosarcoma Cell Line .a 811 to 1458 666 to 19   AAA Possibly primed on the genome, locally A rich (19/21 A in genome downstream of last aligned base) 648/649
(99 %)
2 diff
(99.7 %id)
BX433584 placenta .a 818 to 1456 643 to 1       643/652
(98 %)
14 diff
(97.9 %id)
N56969 multiple sclerosis lesions .a 826 to 1285 461 to 1       461/461
(100 %)
1 diff
(99.8 %id)
AI627316 Kidney .a 826 to 1285 460 to 1       460/460
(100 %)
0 diff
(100 %id)
AI522331 Kidney .a 830 to 1285 455 to 1       455/455
(100 %)
1 diff
(99.8 %id)
AW025434 Kidney .a 851 to 1291 442 to 2       441/442
(99 %)
0 diff
(100 %id)
AI198675   .a 852 to 1288 440 to 4       437/440
(99 %)
0 diff
(100 %id)
BF447325 Prostate .a 852 to 1288 437 to 1       437/437
(100 %)
0 diff
(100 %id)
AI245228 Kidney .a 857 to 1286 430 to 1       430/430
(100 %)
0 diff
(100 %id)
AL526546 brain, neuroblastoma cells, Neuroblastoma Cot 25-normalized .a 858 to 1406 566 to 18   fully sequenced,   549/555
(98 %)
0 diff
(100 %id)
AI023292 liver and spleen .a 868 to 1285 418 to 1       418/418
(100 %)
0 diff
(100 %id)
AI991360 Kidney .a 874 to 1285 412 to 1       412/412
(100 %)
0 diff
(100 %id)
BM992348 Bone, Subchondral Bone .a 878 to 1285 426 to 19   AAA Possibly primed on the genome, locally A rich (19/21 A in genome downstream of last aligned base) 408/408
(100 %)
2 diff
(99.6 %id)
DB508314 testis .a 887 to 1285 1 to 401   AAA Submitted on the opposite strand 401/401
(100 %)
5 diff
(98.8 %id)
AI278426 placenta .a 888 to 1288 402 to 2       401/421
(95 %)
0 diff
(100 %id)
AI141228 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .a 900 to 1285 386 to 1       386/386
(100 %)
0 diff
(100 %id)
AI758391 Kidney .a 905 to 1285 382 to 1       382/382
(100 %)
1 diff
(99.8 %id)
AI015209   .a 908 to 1291 386 to 3       384/386
(99 %)
0 diff
(100 %id)
AI698563 pooled .a 918 to 1288 369 to 1       369/370
(99 %)
11 diff
(97.1 %id)
AW339295 moderately-differentiated endometrialadenocarcinoma, 3 pooled tumors, uterus .a 928 to 1221 295 to 1       295/295
(100 %)
3 diff
(99.0 %id)
BM069505 Islets of Langerhans, Pancreas .a 937 to 1285 372 to 24   fully sequenced, AAA Possibly primed on the genome, locally A rich (19/21 A in genome downstream of last aligned base) 349/349
(100 %)
5 diff
(98.6 %id)
AA631193 colon, colon tumor RER+ .a 939 to 1285 359 to 13   AAA Possibly primed on the genome, locally A rich (19/21 A in genome downstream of last aligned base) 347/347
(100 %)
0 diff
(100 %id)
FN088783 breast carcinoma .a 950 to 1021 1 to 70       70/71
(98 %)
6 diff
(91.6 %id)
AI276935 placenta .a 965 to 1287 322 to 1       322/322
(100 %)
6 diff
(98.2 %id)
AI783529 moderately-differentiated endometrialadenocarcinoma, 3 pooled tumors, uterus .a 983 to 1291 311 to 3       309/311
(99 %)
0 diff
(100 %id)
AI341004 2 pooled tumors (clear cell type), Kidney .a 1010 to 1288 281 to 2       280/281
(99 %)
0 diff
(100 %id)
AI040647 liver and spleen .a 1026 to 1285 260 to 1       260/260
(100 %)
0 diff
(100 %id)
FN157602 breast carcinoma .a 1040 to 1150 1 to 108       108/108
(100 %)
3 diff
(97.3 %id)
AI796321 Kidney .a 1045 to 1284 240 to 1       240/240
(100 %)
0 diff
(100 %id)
AA587411 breast .a 1053 to 1285 243 to 11   AAA Possibly primed on the genome, locally A rich (19/21 A in genome downstream of last aligned base) 233/233
(100 %)
0 diff
(100 %id)
CA943398 Pancreas, Purified pancreatic islet .a 1066 to 1458 408 to 15   fully sequenced, AAA Possibly primed on the genome, locally A rich (19/21 A in genome downstream of last aligned base) 394/394
(100 %)
3 diff
(99.3 %id)
AW627714 2 pooled high-grade transitional celltumors, genitourinary tract .a 1073 to 1288 216 to 1       216/216
(100 %)
0 diff
(100 %id)
BG028100 Bone, osteosarcoma, cell line .a 1074 to 1285 1 to 211   AAA Possibly primed on the genome, locally A rich (19/21 A in genome downstream of last aligned base) 211/211
(100 %)
3 diff
(98.6 %id)
AI148278 senescent fibroblast .a 1131 to 1459 333 to 5       329/333
(98 %)
0 diff
(100 %id)
AA843951 parathyroid gland, parathyroid tumor .a 1158 to 1459 307 to 6       302/307
(98 %)
0 diff
(100 %id)
AW129088 brain, tumor, 5 pooled (see description) .a 1198 to 1458 279 to 19   AAA Possibly primed on the genome, locally A rich (19/21 A in genome downstream of last aligned base) 261/261
(100 %)
0 diff
(100 %id)
AW020508 cochlea, ear .a 1219 to 1458 7 to 246   AAA Possibly primed on the genome, locally A rich (19/21 A in genome downstream of last aligned base) 240/246
(97 %)
6 diff
(97.6 %id)
BU726160 eye, Retina Foveal and Macular .a 1266 to 1458 210 to 18   AAA Possibly primed on the genome, locally A rich (19/21 A in genome downstream of last aligned base) 193/193
(100 %)
0 diff
(100 %id)
FN079665 breast carcinoma .a 1322 to 1385 1 to 62       62/63
(98 %)
2 diff
(96.9 %id)
AY064249   .b 1 to 1245 1 to 1245 exact tiling clone,   1245/1245
(100 %)
0 diff
(100 %id)
NM_078468.2   .b 1 to 1238 1 to 1238 exact RefSeq, AAA Possibly primed on the genome, locally A rich (19/21 A in genome downstream of last aligned base) 1238/1238
(100 %)
0 diff
(100 %id)
BC009771 Brain, primitive neuroectodermal .b 8 to 1247 1 to 1240 G230E available from MGC, AAA Possibly primed on the genome, locally A rich (19/21 A in genome downstream of last aligned base) 1240/1242
(99 %)
6 diff
(99.6 %id)
BQ269000 Pancreas, Purified pancreatic islet .b 10 to 640 1 to 631       631/632
(99 %)
6 diff
(99.1 %id)
AB040451 brain .b 12 to 968 1 to 957 exact     957/957
(100 %)
0 diff
(100 %id)
TI_57186176   .b 16 to 897 52 to 951       898/902
(99 %)
32 diff
(96.5 %id)
BQ929971 leiomyosarcoma, uterus .b 23 to 948 1 to 931       931/932
(99 %)
26 diff
(97.3 %id)
CR592263 placenta .b 24 to 1236 1 to 1213 exact     1213/1213
(100 %)
0 diff
(100 %id)
BX416979 placenta .b 24 to 1007 1 to 984 exact     984/984
(100 %)
2 diff
(99.8 %id)
BM546041 ovary (pool of 3) .b 24 to 1127 21 to 1122 S281A I296F G298S N302D     1102/1122
(98 %)
42 diff
(96.3 %id)
DR159408 human embryonic stem cells differentiated toan early endodermal cell type .b 24 to 823 1 to 800       800/800
(100 %)
0 diff
(100 %id)
DR760185 embryonic stem .b 24 to 828 1 to 805       805/805
(100 %)
0 diff
(100 %id)
AA173098   .b 25 to 442 1 to 419       419/419
(100 %)
3 diff
(99.3 %id)
BQ421346 embryonal carcinoma, cell line, testis .b 26 to 868 1 to 847       845/909
(92 %)
20 diff
(97.8 %id)
BM699674 eye, lens .b 27 to 521 1 to 495     Possibly primed on the genome, locally A rich (19/21 A in genome downstream of last aligned base) 495/495
(100 %)
1 diff
(99.8 %id)
BQ424647 melanotic melanoma, skin .b 37 to 894 1 to 866       866/868
(99 %)
12 diff
(98.7 %id)
BQ687900 ductal carcinoma, cell line, Pancreas .b 40 to 918 1 to 883       883/909
(97 %)
8 diff
(99.2 %id)
BQ068791 brain, neuroblastoma, cell line .b 41 to 935 25 to 928       904/994
(90 %)
18 diff
(98.2 %id)
BU543935 carcinoma, cell line, Prostate .b 42 to 955 1 to 918       918/919
(99 %)
40 diff
(95.7 %id)
BQ924612 large cell carcinoma, lung .b 45 to 939 1 to 898       898/908
(98 %)
10 diff
(98.9 %id)
BQ424426 leiomyosarcoma, uterus .b 60 to 907 1 to 850       850/851
(99 %)
4 diff
(99.6 %id)
BM263172 Islets of Langerhans, Pancreas .b 76 to 636 1 to 561     Possibly primed on the genome, locally A rich (19/21 A in genome downstream of last aligned base) 561/562
(99 %)
1 diff
(99.9 %id)
CR998582 T-Lymphocytes .b 83 to 863 1 to 781       781/781
(100 %)
0 diff
(100 %id)
CF145778 CNCAP(3)T-225 cell line, Prostate .b 163 to 840 1 to 675       675/675
(100 %)
8 diff
(98.9 %id)
CF146349 CNCAP(3)T-225 cell line, Prostate .b 163 to 919 1 to 755       755/755
(100 %)
7 diff
(99.1 %id)
CF146456 CNCAP(3)T-225 cell line, Prostate .b 163 to 896 1 to 730       730/730
(100 %)
10 diff
(98.7 %id)
TI_154178053   .b 170 to 952 70 to 838       769/902
(85 %)
19 diff
(97.9 %id)
TI_154178780   .b 170 to 991 70 to 888       819/819
(100 %)
8 diff
(99.1 %id)
TI_154178901   .b 170 to 1012 68 to 906       839/841
(99 %)
12 diff
(98.6 %id)
N72370 liver and spleen .b 216 to 646 1 to 435       435/435
(100 %)
4 diff
(99.1 %id)
BG421023 Kidney, renal cell adenocarcinoma .b 222 to 1000 1 to 772       772/784
(98 %)
21 diff
(97.4 %id)
BG116169 duodenal adenocarcinoma, cell line, small intestine .b 282 to 1102 1 to 816       816/820
(99 %)
34 diff
(95.9 %id)
TI_57234184   .b 305 to 947 27 to 671       645/671
(96 %)
10 diff
(98.6 %id)
BI907185 leukocyte .b 312 to 947 1 to 638       638/638
(100 %)
5 diff
(99.3 %id)
BE298702 muscle, rhabdomyosarcoma .b 320 to 917 1 to 598       598/598
(100 %)
1 diff
(99.9 %id)
BE297592 muscle, rhabdomyosarcoma .b 320 to 873 1 to 554       554/554
(100 %)
0 diff
(100 %id)
TI_57216748   .b 336 to 1220 34 to 915       882/992
(88 %)
19 diff
(98.1 %id)
T85235 liver and spleen .b 339 to 718 1 to 391       391/402
(97 %)
17 diff
(95.8 %id)
BI756797 brain .b 343 to 1220 7 to 881       875/958
(91 %)
14 diff
(98.6 %id)
TI_149286966   .b 343 to 1238 950 to 58   AAA Possibly primed on the genome, locally A rich (19/21 A in genome downstream of last aligned base) 891/1183
(75 %)
22 diff
(98.2 %id)
CK904841 Islets of Langerhans, Pancreas .b 362 to 937 12 to 587       576/587
(98 %)
6 diff
(99.0 %id)
BM055187 Islets of Langerhans, Pancreas .b 367 to 921 1 to 555       555/555
(100 %)
0 diff
(100 %id)
BM055414 Islets of Langerhans, Pancreas .b 367 to 828 1 to 462   fully sequenced,   462/462
(100 %)
0 diff
(100 %id)
BM699098 eye, fetal eyes .b 391 to 765 1 to 375     Possibly primed on the genome, locally A rich (19/21 A in genome downstream of last aligned base) 375/375
(100 %)
0 diff
(100 %id)
BU902277 leiomyosarcoma, uterus .b 396 to 1134 11 to 760       750/1248
(60 %)
29 diff
(97.7 %id)
N77177 liver and spleen .b 400 to 668 1 to 277     Possibly primed on the genome, locally A rich (19/21 A in genome downstream of last aligned base) 276/277
(99 %)
13 diff
(95.4 %id)
AI400282 pooled .b 414 to 904 1 to 491     Submitted on the opposite strand 491/491
(100 %)
5 diff
(99.0 %id)
BM823204 stomach .b 420 to 854 1 to 435       435/435
(100 %)
0 diff
(100 %id)
BU602026 mixed (pool of 40 RNAs) .b 433 to 1242 7 to 818       812/837
(97 %)
16 diff
(98.1 %id)
BM716747 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .b 445 to 1152 1 to 708       708/708
(100 %)
5 diff
(99.3 %id)
DN917992   .b 455 to 1072 14 to 631       618/631
(97 %)
6 diff
(99.1 %id)
N28003 melanocyte .b 466 to 832 1 to 367   fully sequenced,   367/367
(100 %)
0 diff
(100 %id)
TI_149287489   .b 482 to 1238 845 to 87   AAA Possibly primed on the genome, locally A rich (19/21 A in genome downstream of last aligned base) 759/1163
(65 %)
30 diff
(97.5 %id)
CN364341 embryonic stem cells, cell lines H1, H7, andH9 .b 516 to 980 1 to 465       465/465
(100 %)
1 diff
(99.8 %id)
TI_149277201   .b 526 to 1246 803 to 85   AAA Possibly primed on the genome, locally A rich (19/21 A in genome downstream of last aligned base) 719/722
(99 %)
5 diff
(99.4 %id)
BU608186 Human Lung Epithelial cells, lung .b 559 to 1238 698 to 19   AAA Possibly primed on the genome, locally A rich (19/21 A in genome downstream of last aligned base) 680/680
(100 %)
2 diff
(99.8 %id)
BQ008485 Chondrosarcoma, Left Pubic Bone .b 562 to 1248 700 to 14   tiling clone, AAA Possibly primed on the genome, locally A rich (19/21 A in genome downstream of last aligned base) 687/687
(100 %)
1 diff
(99.9 %id)
CA503410 Human Lung Epithelial cells, lung .b 562 to 1238 695 to 19   AAA Possibly primed on the genome, locally A rich (19/21 A in genome downstream of last aligned base) 677/677
(100 %)
1 diff
(99.9 %id)
BU625721 cell lines, Enchondroma .b 563 to 1246 700 to 19   AAA Possibly primed on the genome, locally A rich (19/21 A in genome downstream of last aligned base) 682/682
(100 %)
2 diff
(99.8 %id)
BE464077 pooled germ cell tumors .b 564 to 1238 673 to 1       673/673
(100 %)
3 diff
(99.6 %id)
BM968058 lung, Primary Lung Epithelial Cells .b 565 to 1246 696 to 16   AAA Possibly primed on the genome, locally A rich (19/21 A in genome downstream of last aligned base) 681/681
(100 %)
3 diff
(99.6 %id)
BU737496 eye, lens .b 575 to 1238 682 to 19   AAA Possibly primed on the genome, locally A rich (19/21 A in genome downstream of last aligned base) 664/664
(100 %)
2 diff
(99.7 %id)
BF767744 colon_normal .b 610 to 854 249 to 7     Submitted on the opposite strand 243/249
(97 %)
1 diff
(99.6 %id)
BQ020226 Chondrosarcoma, Left Pubic Bone .b 612 to 1243 646 to 14   AAA Possibly primed on the genome, locally A rich (19/21 A in genome downstream of last aligned base) 633/633
(100 %)
2 diff
(99.7 %id)
DN917991   .b 619 to 1244 629 to 4       626/631
(99 %)
4 diff
(99.4 %id)
BM972795 lung .b 636 to 1238 621 to 19   AAA Possibly primed on the genome, locally A rich (19/21 A in genome downstream of last aligned base) 603/604
(99 %)
4 diff
(99.4 %id)
CK904840 Islets of Langerhans, Pancreas .b 671 to 1238 580 to 13   AAA Possibly primed on the genome, locally A rich (19/21 A in genome downstream of last aligned base) 568/568
(100 %)
1 diff
(99.9 %id)
TI_151752299   .b 674 to 1245 594 to 20       575/828
(69 %)
14 diff
(98.4 %id)
BM972365 lung .b 686 to 1238 569 to 19   AAA Possibly primed on the genome, locally A rich (19/21 A in genome downstream of last aligned base) 551/551
(100 %)
3 diff
(99.5 %id)
BM142468 Islets of Langerhans, Pancreas .b 721 to 1243 533 to 11   AAA Possibly primed on the genome, locally A rich (19/21 A in genome downstream of last aligned base) 523/523
(100 %)
0 diff
(100 %id)
BQ268729 Pancreas, Purified pancreatic islet .b 724 to 1239 516 to 1       516/516
(100 %)
0 diff
(100 %id)
BM054941 Islets of Langerhans, Pancreas .b 729 to 1238 522 to 13   AAA Possibly primed on the genome, locally A rich (19/21 A in genome downstream of last aligned base) 510/510
(100 %)
0 diff
(100 %id)
FN091051 breast carcinoma .b 735 to 837 99 to 1     Submitted on the opposite strand 99/99
(100 %)
4 diff
(96.0 %id)
AA809348 germinal center B cell .b 741 to 1247 515 to 9       507/515
(98 %)
0 diff
(100 %id)
AI819929 2 pooled tumors (clear cell type), Kidney .b 743 to 1243 511 to 11   AAA Possibly primed on the genome, locally A rich (19/21 A in genome downstream of last aligned base) 501/501
(100 %)
4 diff
(99.3 %id)
AI344302 colon, colon tumor, RER+ .b 746 to 1245 500 to 1       500/500
(100 %)
1 diff
(99.8 %id)
AI763252 2 pooled tumors (clear cell type), Kidney .b 748 to 1245 501 to 4       498/501
(99 %)
0 diff
(100 %id)
AI770088 2 pooled tumors (clear cell type), Kidney .b 748 to 1231 490 to 6       485/490
(98 %)
0 diff
(100 %id)
AI887630 serous papillary carcinoma, high grade, 2pooled tumors, uterus .b 748 to 1241 494 to 1       494/494
(100 %)
0 diff
(100 %id)
AA036771.
matches multiple genes
uterus .b 750 to 1238 497 to 1     also hits gene CAMSAP1L1 497/498
(99 %)
15 diff
(97.0 %id)
AI368682   .b 751 to 1242 493 to 2       492/493
(99 %)
0 diff
(100 %id)
BE044584 pooled .b 753 to 1247 498 to 4       495/498
(99 %)
0 diff
(100 %id)
BM055114 Islets of Langerhans, Pancreas .b 767 to 1245 484 to 6   fully sequenced,   479/484
(98 %)
0 diff
(100 %id)
BM669756 eye, fetal eyes .b 773 to 1246 489 to 16   AAA Possibly primed on the genome, locally A rich (19/21 A in genome downstream of last aligned base) 474/474
(100 %)
0 diff
(100 %id)
AA772645 parathyroid gland, parathyroid tumor .b 785 to 1245 467 to 7       461/467
(98 %)
0 diff
(100 %id)
N21343 melanocyte .b 802 to 1238 437 to 1   fully sequenced,   437/437
(100 %)
2 diff
(99.6 %id)
N54989 liver and spleen .b 815 to 1238 438 to 14   AAA Possibly primed on the genome, locally A rich (19/21 A in genome downstream of last aligned base) 425/425
(100 %)
6 diff
(98.6 %id)
AA173268   .b 825 to 1238 418 to 1       418/418
(100 %)
6 diff
(98.6 %id)
T89195 liver and spleen .b 967 to 1238 272 to 1       272/276
(98 %)
3 diff
(99.0 %id)
N52642 liver and spleen .b 969 to 1243 276 to 1       276/276
(100 %)
7 diff
(97.5 %id)
NM_078469.2   .c 1 to 2349 1 to 2349 exact RefSeq, AAA Possibly primed on the genome, locally A rich (19/21 A in genome downstream of last aligned base) 2349/2349
(100 %)
0 diff
(100 %id)
AK055691   .c 12 to 2349 1 to 2339 K75R tiling clone, available from FLJ,   2339/2339
(100 %)
4 diff
(99.9 %id)
DA604329   .c 13 to 526 2 to 515   capped   514/514
(100 %)
2 diff
(99.7 %id)
BM709567 eye, optic nerve .c 18 to 594 1 to 577   fully sequenced, Possibly primed on the genome, locally A rich (19/21 A in genome downstream of last aligned base) 577/577
(100 %)
0 diff
(100 %id)
BM919929 pooled pancreas and spleen .c 21 to 948 1 to 937 K235*     937/1026
(91 %)
20 diff
(98.1 %id)
AL834458 brain .c 23 to 2348 1 to 2326 exact tiling clone, available from DKFZ, AAA Possibly primed on the genome, locally A rich (19/21 A in genome downstream of last aligned base) 2326/2326
(100 %)
1 diff
(100.0 %id)
BU181895 eye, retinoblastoma .c 29 to 964 1 to 933       933/933
(100 %)
21 diff
(97.8 %id)
BM455049 lymph, lymphoma, cell line .c 43 to 1066 1 to 1031       1031/1128
(91 %)
30 diff
(97.4 %id)
CR626197 Neuroblastoma Cot 25-normalized .c 318 to 2290 1 to 1973   tiling clone,   1973/1973
(100 %)
0 diff
(100 %id)
BX332464 Neuroblastoma Cot 25-normalized .c 318 to 1296 1 to 970   fully sequenced,   970/970
(100 %)
10 diff
(99.0 %id)
DA731073   .c 370 to 1235 2 to 874   capped   873/873
(100 %)
12 diff
(98.7 %id)
W78773 liver and spleen .c 408 to 828 1 to 420   fully sequenced,   420/420
(100 %)
1 diff
(99.8 %id)
EB387154 eye, optic nerve .c 415 to 1259 1 to 845       845/845
(100 %)
0 diff
(100 %id)
R92534 liver and spleen .c 428 to 870 19 to 475       457/477
(95 %)
20 diff
(95.9 %id)
H74112 liver and spleen .c 428 to 777 2 to 355       354/357
(99 %)
5 diff
(98.6 %id)
BG032117 breast, mammary adenocarcinoma, cell line .c 521 to 1164 1 to 646       646/689
(93 %)
6 diff
(99.2 %id)
BU733579 eye, optic nerve .c 564 to 1156 610 to 19   fully sequenced, AAA Possibly primed on the genome, locally A rich (19/21 A in genome downstream of last aligned base) 592/592
(100 %)
0 diff
(100 %id)
R18762 whole brain .c 627 to 973 1 to 354     Possibly primed on the genome, locally A rich (19/21 A in genome downstream of last aligned base) 354/355
(99 %)
19 diff
(94.7 %id)
BM724077 eye, fetal eye .c 638 to 1353 1 to 714     Possibly primed on the genome, locally A rich (19/21 A in genome downstream of last aligned base) 714/714
(100 %)
3 diff
(99.6 %id)
BU183216 bone marrow, from acute myelogenous leukemia .c 644 to 1440 1 to 798       798/798
(100 %)
22 diff
(97.3 %id)
N70663 lung .c 722 to 1156 435 to 1       435/437
(99 %)
2 diff
(99.6 %id)
AI863616 Kidney .c 748 to 1167 425 to 6       420/425
(98 %)
0 diff
(100 %id)
AA629375   .c 764 to 1167 407 to 3       405/407
(99 %)
0 diff
(100 %id)
CX163594 human embryonic stem cells differentiated toan early endodermal cell type .c 776 to 1625 1 to 850       850/850
(100 %)
5 diff
(99.5 %id)
W81124 liver and spleen .c 789 to 1156 369 to 1   fully sequenced,   369/369
(100 %)
5 diff
(98.7 %id)
BP265514 thyroid .c 790 to 1371 1 to 582       582/582
(100 %)
6 diff
(99.0 %id)
BQ881504 dorsal root ganglia .c 797 to 1499 1 to 720       720/1064
(67 %)
6 diff
(99.5 %id)
CX784158 human embryonic stem cells .c 805 to 1521 1 to 717       717/717
(100 %)
1 diff
(99.9 %id)
N94340 senescent fibroblast .c 835 to 1160 335 to 6       330/336
(98 %)
0 diff
(100 %id)
H73920 liver and spleen .c 843 to 1247 407 to 1       407/407
(100 %)
9 diff
(97.8 %id)
H71127 liver and spleen .c 858 to 1253 404 to 7       398/408
(97 %)
0 diff
(100 %id)
R92443 liver and spleen .c 1117 to 1247 131 to 1       131/131
(100 %)
1 diff
(99.3 %id)
BX332463 Neuroblastoma Cot 25-normalized .c 1266 to 2290 1020 to 1   fully sequenced,   1020/1020
(100 %)
11 diff
(99.0 %id)
BM680270 eye, fetal eye .c 1624 to 2343 738 to 19   AAA Possibly primed on the genome, locally A rich (19/21 A in genome downstream of last aligned base) 720/720
(100 %)
0 diff
(100 %id)
DB363136   .c 1773 to 2349 575 to 1       575/575
(100 %)
11 diff
(98.1 %id)
DB320023   .c 1795 to 2349 555 to 1       555/555
(100 %)
2 diff
(99.7 %id)
R43084 whole brain .c 1978 to 2349 393 to 11   AAA Possibly primed on the genome, locally A rich (19/21 A in genome downstream of last aligned base) 383/385
(99 %)
13 diff
(96.7 %id)
AK300767   .d 1 to 997 1 to 997 exact tiling clone,   997/997
(100 %)
0 diff
(100 %id)
BE465460 Kidney .d 682 to 1130 464 to 16   tiling clone, AAA Possibly primed on the genome, locally A rich (19/21 A in genome downstream of last aligned base) 449/449
(100 %)
0 diff
(100 %id)
FN158694 breast carcinoma .d 954 to 1042 1 to 86       86/86
(100 %)
3 diff
(96.6 %id)
BF831013 head_neck .d 959 to 1124 14 to 179       166/179
(92 %)
6 diff
(96.7 %id)
BF830830 head_neck .d 965 to 1124 1 to 160       160/160
(100 %)
2 diff
(98.8 %id)
CF455715 peripheral nervous system .d 1129 to 2174 36 to 1080   tiling clone,   1045/1080
(96 %)
6 diff
(99.5 %id)
AA442556   .d 1141 to 1702 11 to 572   tiling clone,   562/572
(98 %)
6 diff
(99.0 %id)
BF984736 duodenal adenocarcinoma, cell line, small intestine .d 1160 to 1898 1 to 731       731/940
(77 %)
20 diff
(97.9 %id)
AA040555 heart .d 1213 to 1549 1 to 338       338/341
(99 %)
4 diff
(98.9 %id)
BQ651404 hepatocellular carcinoma, cell line, Liver .d 1279 to 2062 1 to 790       790/924
(85 %)
21 diff
(97.8 %id)
BI857846 breast, mammary adenocarcinoma, cell line .d 1335 to 2019 1 to 704       704/859
(81 %)
26 diff
(97.0 %id)
TI_57190935   .d 1335 to 2019 51 to 754       704/859
(81 %)
26 diff
(97.0 %id)
W24435 lung .d 1442 to 1678 1 to 237       237/238
(99 %)
1 diff
(99.6 %id)
TI_149273342   .d 1456 to 2317 934 to 87   tiling clone, AAA Possibly primed on the genome, locally A rich (19/21 A in genome downstream of last aligned base) 848/848
(100 %)
19 diff
(97.8 %id)
W22411 eye, retina .d 1484 to 1995 11 to 530       520/628
(82 %)
16 diff
(97.5 %id)
BG403458 bladder, transitional cell papilloma, cell line .d 1492 to 2285 1 to 799       799/844
(94 %)
34 diff
(96.0 %id)
TI_149309243   .d 1541 to 2323 870 to 95   AAA Possibly primed on the genome, locally A rich (19/21 A in genome downstream of last aligned base) 776/937
(82 %)
11 diff
(98.9 %id)
BU631350 cell lines, Chondrosarcoma .d 1574 to 2317 755 to 19   AAA Possibly primed on the genome, locally A rich (19/21 A in genome downstream of last aligned base) 737/745
(98 %)
7 diff
(99.1 %id)
BU619932 cell lines, Chondrosarcoma .d 1574 to 2317 752 to 19   AAA Possibly primed on the genome, locally A rich (19/21 A in genome downstream of last aligned base) 734/737
(99 %)
11 diff
(98.6 %id)
CR742022 liver and spleen .d 1607 to 2307 1 to 702       702/702
(100 %)
1 diff
(99.9 %id)
T86027 liver and spleen .d 1608 to 1943 1 to 345   fully sequenced,   345/345
(100 %)
18 diff
(94.8 %id)
TI_149292706   .d 1634 to 2314 766 to 87   AAA Possibly primed on the genome, locally A rich (19/21 A in genome downstream of last aligned base) 680/681
(99 %)
4 diff
(99.5 %id)
BU687657 lung .d 1636 to 2323 705 to 19   AAA Possibly primed on the genome, locally A rich (19/21 A in genome downstream of last aligned base) 687/687
(100 %)
2 diff
(99.8 %id)
BM696871 eye, lens .d 1653 to 2302 1 to 650   AAA Possibly primed on the genome, locally A rich (19/21 A in genome downstream of last aligned base) 650/652
(99 %)
1 diff
(99.9 %id)
BM974774 lung .d 1654 to 2314 676 to 17   AAA Possibly primed on the genome, locally A rich (19/21 A in genome downstream of last aligned base) 660/660
(100 %)
4 diff
(99.4 %id)
AW952109   .d 1660 to 2054 1 to 396       396/396
(100 %)
12 diff
(97.0 %id)
BU675753 lung, Primary Lung Epithelial Cells .d 1688 to 2317 648 to 19   AAA Possibly primed on the genome, locally A rich (19/21 A in genome downstream of last aligned base) 630/630
(100 %)
0 diff
(100 %id)
BQ371360 prostate_normal .d 1702 to 2057 10 to 365       356/365
(97 %)
9 diff
(97.6 %id)
BU619069 Cell Line, Chondrosarcoma .d 1724 to 2317 612 to 19   AAA Possibly primed on the genome, locally A rich (19/21 A in genome downstream of last aligned base) 594/594
(100 %)
1 diff
(99.9 %id)
DB367019   .d 1755 to 2317 560 to 1       560/560
(100 %)
14 diff
(97.5 %id)
BM994977 Chondrosarcoma, Left Pubic Bone .d 1756 to 2317 579 to 19   AAA Possibly primed on the genome, locally A rich (19/21 A in genome downstream of last aligned base) 561/561
(100 %)
1 diff
(99.9 %id)
AW802018 uterus .d 1767 to 2157 407 to 17       391/407
(96 %)
0 diff
(100 %id)
AA029422 heart .d 1768 to 1933 1 to 166       166/166
(100 %)
0 diff
(100 %id)
AJ312122 thyroid tumour .d 1792 to 2321 1 to 530       530/530
(100 %)
1 diff
(99.9 %id)
DB484330 hypothalamus .d 1821 to 2252 1 to 433       433/434
(99 %)
2 diff
(99.6 %id)
DB484349 hypothalamus .d 1821 to 2251 1 to 431       431/431
(100 %)
3 diff
(99.4 %id)
BP394237 pancreatic islet .d 1823 to 2323 1 to 501     Submitted on the opposite strand 501/501
(100 %)
0 diff
(100 %id)
AI373643 Kidney .d 1827 to 2317 491 to 1       491/491
(100 %)
0 diff
(100 %id)
AI554170 pooled .d 1828 to 2317 490 to 1       490/490
(100 %)
0 diff
(100 %id)
AA236398 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .d 1829 to 2134 1 to 303   fully sequenced,   303/303
(100 %)
4 diff
(98.7 %id)
AW271208 Kidney .d 1834 to 2317 484 to 1       484/484
(100 %)
0 diff
(100 %id)
AI189273 placenta .d 1847 to 2324 480 to 3   tiling clone,   478/480
(99 %)
0 diff
(100 %id)
AW802037 uterus .d 1860 to 2157 308 to 11       298/308
(96 %)
0 diff
(100 %id)
AW802203 uterus .d 1862 to 2146 288 to 4       285/288
(98 %)
0 diff
(100 %id)
N92258 lung .d 1863 to 2315 457 to 1       457/457
(100 %)
10 diff
(97.9 %id)
AA040583 heart .d 1868 to 2317 449 to 1       449/450
(99 %)
1 diff
(99.8 %id)
AW974403   .d 1882 to 2319 553 to 116     Submitted on the opposite strand 438/554
(79 %)
0 diff
(100 %id)
DB553285 hypothalamus .d 1884 to 2314 1 to 432     Submitted on the opposite strand 432/432
(100 %)
2 diff
(99.6 %id)
DB553264 hypothalamus .d 1886 to 2314 1 to 430     Submitted on the opposite strand 430/430
(100 %)
4 diff
(99.1 %id)
AI160084 heart .d 1893 to 2317 425 to 1       425/425
(100 %)
0 diff
(100 %id)
AW612285 Kidney .d 1898 to 2317 420 to 1       420/420
(100 %)
0 diff
(100 %id)
BF514690   .d 1898 to 2323 443 to 18   AAA Possibly primed on the genome, locally A rich (19/21 A in genome downstream of last aligned base) 426/426
(100 %)
0 diff
(100 %id)
BQ013028 placenta .d 1900 to 2323 442 to 19   AAA Possibly primed on the genome, locally A rich (19/21 A in genome downstream of last aligned base) 424/424
(100 %)
0 diff
(100 %id)
AI753843 bone marrow stroma .d 1905 to 2317 431 to 19   AAA Possibly primed on the genome, locally A rich (19/21 A in genome downstream of last aligned base) 413/413
(100 %)
0 diff
(100 %id)
BE677520 dorsal root ganglia .d 1906 to 2324 419 to 1       419/419
(100 %)
0 diff
(100 %id)
T91245 liver and spleen .d 1933 to 2324 415 to 10   fully sequenced,   406/415
(97 %)
0 diff
(100 %id)
BE048851 Kidney .d 1942 to 2319 378 to 1       378/378
(100 %)
0 diff
(100 %id)
AA939123 pooled .d 1950 to 2319 370 to 2       369/370
(99 %)
0 diff
(100 %id)
AI266493 placenta .d 1950 to 2319 371 to 4       368/371
(99 %)
0 diff
(100 %id)
AW510624 pooled .d 1954 to 2324 370 to 1       370/370
(100 %)
2 diff
(99.5 %id)
AW768248 lymph node, lymphoma, follicular mixed small and largecell .d 1954 to 2314 361 to 1       361/361
(100 %)
0 diff
(100 %id)
AA806484 germinal center B cell .d 1962 to 2323 386 to 25   AAA Possibly primed on the genome, locally A rich (19/21 A in genome downstream of last aligned base) 362/362
(100 %)
0 diff
(100 %id)
AA730965 Ewing's sarcoma .d 1963 to 2316 354 to 2       353/354
(99 %)
0 diff
(100 %id)
BQ011906 placenta .d 1963 to 2317 373 to 19   AAA Possibly primed on the genome, locally A rich (19/21 A in genome downstream of last aligned base) 355/355
(100 %)
0 diff
(100 %id)
AA974289 pooled germ cell tumors .d 1964 to 2323 359 to 1       359/359
(100 %)
1 diff
(99.8 %id)
AA603033 normal prostate, Prostate .d 1970 to 2319 355 to 7       349/355
(98 %)
0 diff
(100 %id)
AW577636 breast .d 2016 to 2297 283 to 2       282/285
(98 %)
0 diff
(100 %id)
AW577642 breast .d 2016 to 2298 304 to 23       282/306
(92 %)
0 diff
(100 %id)
AA761715 germinal center B cell .d 2044 to 2323 308 to 29   AAA Possibly primed on the genome, locally A rich (19/21 A in genome downstream of last aligned base) 280/281
(99 %)
0 diff
(100 %id)
AA649130 Ewing's sarcoma .d 2045 to 2316 273 to 2       272/273
(99 %)
0 diff
(100 %id)
BQ011998 placenta .d 2072 to 2323 270 to 19   AAA Possibly primed on the genome, locally A rich (19/21 A in genome downstream of last aligned base) 252/252
(100 %)
0 diff
(100 %id)
AA236399 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .d 2104 to 2322 219 to 1   fully sequenced,   219/219
(100 %)
0 diff
(100 %id)
AA029423 heart .d 2179 to 2323 145 to 1       145/145
(100 %)
0 diff
(100 %id)
AI813262 2 pooled tumors (clear cell type), Kidney .d 2189 to 2319 131 to 1       420/456
(92 %)
43 diff
(90.6 %id)
BQ269194 Pancreas, Purified pancreatic islet .e 1 to 618 13 to 630   tiling clone,   618/630
(98 %)
6 diff
(99.1 %id)
AY092061   .e 9 to 1468 3 to 1467   tiling clone, AAA Possibly primed on the genome, locally A rich (19/21 A in genome downstream of last aligned base) 1465/1467
(99 %)
16 diff
(99.0 %id)
BQ268922 Pancreas, Purified pancreatic islet .e 882 to 1475 594 to 1       594/594
(100 %)
1 diff
(99.9 %id)
FN113618 breast carcinoma .e 890 to 969 1 to 78       78/94
(82 %)
5 diff
(94.7 %id)
AI191878 heart .e 1202 to 1653 452 to 1   tiling clone,   452/452
(100 %)
0 diff
(100 %id)
BF064199 colon, colon tumor, RER+ .e 1217 to 1473 261 to 4       258/261
(98 %)
0 diff
(100 %id)
AK304529 uterus .f 1 to 1379 1 to 1379 exact tiling clone,   1379/1379
(100 %)
1 diff
(100.0 %id)
DC420250 uterus .f 1 to 486 1 to 486       486/486
(100 %)
0 diff
(100 %id)
CN364355 embryonic stem cells, DMSO-treated H9 cellline .f 10 to 424 1 to 415       415/415
(100 %)
4 diff
(99.1 %id)
BM468844 duodenal adenocarcinoma, cell line, small intestine .g 1 to 734 1 to 742   tiling clone,   742/984
(75 %)
18 diff
(98.2 %id)
AW590858 pooled germ cell tumors .g 599 to 1092 494 to 1   tiling clone,   494/494
(100 %)
1 diff
(99.8 %id)
AI652798 pooled germ cell tumors .g 629 to 1092 464 to 1   tiling clone,   464/464
(100 %)
3 diff
(99.4 %id)
BI048107 stomach .h 1 to 515 1 to 517 V2L P6R P9Q V10S Q11A ... tiling clone,   517/517
(100 %)
22 diff
(95.8 %id)
BI047995 stomach .h 12 to 517 12 to 516   tiling clone,   505/517
(97 %)
8 diff
(98.5 %id)
DR001985 fetal brain .i 1 to 733 1 to 734 exact tiling clone,   734/734
(100 %)
5 diff
(99.4 %id)
DB272933 uterus .i 13 to 571 2 to 560 exact capped   559/559
(100 %)
1 diff
(99.9 %id)
BX480541   .j-u 1 to 587 8 to 594   tiling clone,   594/594
(100 %)
2 diff
(99.7 %id)
CN364344 embryonic stem cells, cell lines H1, H7, andH9 .j-u 16 to 302 1 to 296       296/296
(100 %)
8 diff
(97.3 %id)
CV379618 marrow .j-u 367 to 672 308 to 7   tiling clone, Submitted on the opposite strand 302/308
(98 %)
0 diff
(100 %id)
CV377334 colon_normal .j-u 458 to 857 1 to 400   tiling clone,   400/401
(99 %)
6 diff
(98.6 %id)
BU947442 insulinoma, Pancreas .k-u 1 to 582 1 to 582   tiling clone,   582/582
(100 %)
7 diff
(98.8 %id)
BF767562 colon_normal .k-u 358 to 670 1 to 313   tiling clone,   313/313
(100 %)
7 diff
(97.8 %id)
CD000188 Pooled-Skin .k-u 521 to 1301 1 to 785   tiling clone,   785/785
(100 %)
20 diff
(97.5 %id)
AA445970   .k-u 836 to 1229 1 to 393       393/393
(100 %)
2 diff
(99.5 %id)
BQ013732 placenta .k-u 991 to 1574 598 to 18   AAA Possibly primed on the genome, locally A rich (19/21 A in genome downstream of last aligned base) 581/583
(99 %)
4 diff
(99.4 %id)
AA424225   .k-u 1107 to 1529 1 to 423       423/423
(100 %)
0 diff
(100 %id)
AI672429 Kidney .k-u 1125 to 1581 459 to 2       458/459
(99 %)
0 diff
(100 %id)
AA913890 pooled .k-u 1137 to 1583 448 to 2       447/448
(99 %)
0 diff
(100 %id)
BF510125   .k-u 1139 to 1574 453 to 18   AAA Possibly primed on the genome, locally A rich (19/21 A in genome downstream of last aligned base) 436/436
(100 %)
1 diff
(99.8 %id)
AI758166 Kidney .k-u 1142 to 1579 453 to 1       453/481
(94 %)
20 diff
(95.9 %id)
AA601941   .k-u 1145 to 1520 1 to 375       375/375
(100 %)
7 diff
(98.2 %id)
AA977824 Kidney, kidney tumor .k-u 1146 to 1580 435 to 1   tiling clone,   435/435
(100 %)
0 diff
(100 %id)
AA426375.
matches multiple genes
  .k-u 1148 to 1581 435 to 2     also hits gene chorspybu 434/435
(99 %)
0 diff
(100 %id)
AA152326.
matches multiple genes
uterus .k-u 1155 to 1579 425 to 1     also hits gene SAT2 425/425
(100 %)
4 diff
(99.1 %id)
BF224002 pooled germ cell tumors .k-u 1177 to 1579 403 to 1       403/403
(100 %)
1 diff
(99.8 %id)
AW470717 2 pooled tumors (clear cell type), Kidney .k-u 1186 to 1579 404 to 11   AAA Possibly primed on the genome, locally A rich (19/21 A in genome downstream of last aligned base) 394/394
(100 %)
0 diff
(100 %id)
BG236091 blood, lymphocyte .k-u 1188 to 1573 386 to 1       386/386
(100 %)
0 diff
(100 %id)
AI263035 Kidney .k-u 1192 to 1581 391 to 2       390/391
(99 %)
0 diff
(100 %id)
AI806027 pooled .k-u 1192 to 1583 396 to 5       392/396
(98 %)
0 diff
(100 %id)
FN058868 breast carcinoma .k-u 1214 to 1315 1 to 102       102/103
(99 %)
1 diff
(99.1 %id)
AW591510 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .k-u 1226 to 1574 372 to 24   AAA Possibly primed on the genome, locally A rich (19/21 A in genome downstream of last aligned base) 349/349
(100 %)
0 diff
(100 %id)
AI582163 lung, squamous cell carcinoma, poorlydifferentiated (4 pooled tumors, including primary andmetastatic) .k-u 1228 to 1574 373 to 27   AAA Possibly primed on the genome, locally A rich (19/21 A in genome downstream of last aligned base) 347/347
(100 %)
1 diff
(99.8 %id)
CF529004 placenta .k-u 1230 to 1574 362 to 18   AAA Possibly primed on the genome, locally A rich (19/21 A in genome downstream of last aligned base) 345/345
(100 %)
2 diff
(99.5 %id)
AW386929 pnet .k-u 1235 to 1542 1 to 310       310/322
(96 %)
22 diff
(93.2 %id)
T50315 fetal spleen, Spleen .k-u 1248 to 1571 334 to 1       334/374
(89 %)
12 diff
(96.8 %id)
AW015962   .k-u 1282 to 1574 311 to 19   AAA Possibly primed on the genome, locally A rich (19/21 A in genome downstream of last aligned base) 293/293
(100 %)
5 diff
(98.3 %id)
AI908554 breast .k-u 1292 to 1490 1 to 199       199/209
(95 %)
1 diff
(99.6 %id)
BM817941 stomach .k-u 1309 to 1574 1 to 266   AAA Possibly primed on the genome, locally A rich (19/21 A in genome downstream of last aligned base) 266/266
(100 %)
2 diff
(99.3 %id)
BU753530 placenta .k-u 1349 to 1579 243 to 13   AAA Possibly primed on the genome, locally A rich (19/21 A in genome downstream of last aligned base) 231/231
(100 %)
0 diff
(100 %id)
BQ011995 placenta .k-u 1349 to 1574 244 to 19   AAA Possibly primed on the genome, locally A rich (19/21 A in genome downstream of last aligned base) 226/226
(100 %)
0 diff
(100 %id)
FN159190 breast carcinoma .k-u 1353 to 1457 9 to 112       104/112
(92 %)
4 diff
(96.5 %id)
BF431119 Kidney .k-u 1364 to 1583 220 to 1       220/220
(100 %)
0 diff
(100 %id)
T34661 ovary .k-u 1367 to 1549 37 to 219       183/219
(83 %)
1 diff
(99.6 %id)
DB521537.
matches multiple genes
testis .k-u 1371 to 1831 461 to 1   tiling clone, also hits gene DHX32 461/461
(100 %)
0 diff
(100 %id)
AI273814 ovary, tumor, 5 pooled (see description) .k-u 1376 to 1574 199 to 1       199/199
(100 %)
1 diff
(99.5 %id)
AI818394 adenocarcinoma, Pancreas .k-u 1437 to 1582 164 to 19   AAA Possibly primed on the genome, locally A rich (19/21 A in genome downstream of last aligned base) 146/146
(100 %)
0 diff
(100 %id)
DN915263   .k-u 1548 to 1787 9 to 248       240/248
(96 %)
6 diff
(97.6 %id)
AW380273 head_neck .k-u 1634 to 1839 22 to 226       205/241
(85 %)
6 diff
(97.6 %id)
AA855106 parathyroid gland, parathyroid tumor .k-u 1740 to 2060 329 to 9   tiling clone,   321/329
(97 %)
0 diff
(100 %id)
BG026952 Bone, osteosarcoma, cell line .l 1 to 746 1 to 736   tiling clone,   736/742
(99 %)
17 diff
(97.8 %id)
BM467271 duodenal adenocarcinoma, cell line, small intestine .l 606 to 1451 1 to 856 I10L R18K T21Y Q22P C23V ... tiling clone,   854/1178
(72 %)
29 diff
(97.6 %id)
DB170421 kidney, tumor tissue .m-u 1 to 597 2 to 598 exact tiling clone, capped   597/597
(100 %)
0 diff
(100 %id)
DA493196 brain .m-u 18 to 584 2 to 568 exact capped   567/567
(100 %)
0 diff
(100 %id)
DA301180 hippocampus .m-u 42 to 615 2 to 576 A43C R44S S45E N46Q H47P ... tiling clone, capped   575/575
(100 %)
1 diff
(99.9 %id)
CV574199 cornea, eye .n-u 1 to 601 1 to 601 exact tiling clone,   601/601
(100 %)
1 diff
(99.9 %id)
AA303102 uterus .n-u 12 to 423 1 to 412     Submitted on the opposite strand 412/412
(100 %)
0 diff
(100 %id)
AA340281 brain Gene BCCIP, variant not shown         Submitted on the opposite strand    
AK092054   Gene BCCIP, variant not shown       available from FLJ,      
DA101769 cerebellum Gene BCCIP, variant not shown       capped      
AV648493 corresponding non cancerous liver tissue Gene BCCIP, variant not shown         Submitted on the opposite strand, submitted on the opposite strand    
DB460445.
matches multiple genes
testis Gene BCCIP, variant not shown         This clone was ignored, also hits gene DHX32    
DB460445.
matches multiple genes
testis Gene DHX32, variant not shown         This clone was ignored, also hits gene DHX32    
DB525856.
matches multiple genes
testis Gene BCCIP, variant not shown         This clone was ignored, also hits gene DHX32    
DB525856.
matches multiple genes
testis Gene DHX32, variant not shown         This clone was ignored, also hits gene DHX32    
N68658 liver and spleen Gene BCCIP, variant not shown              
AW189114 serous papillary carcinoma, high grade, 2pooled tumors, uterus Gene BCCIP, variant not shown              
BE504980 pooled germ cell tumors Gene BCCIP, variant not shown         Suspected internal deletion, this clone was ignored    
BE550306 pooled germ cell tumors Gene BCCIP, variant not shown         Suspected internal deletion, this clone was ignored    
BF219244 brain, glioblastoma Gene BCCIP, variant not shown         This clone was ignored    
BU953265 mixed (pool of 40 RNAs) Gene BCCIP, variant not shown         Suspected internal deletion, this clone was ignored    
CX787502 human embryonic stem cells Gene BCCIP, variant not shown         Suspected internal deletion, this clone was ignored    
DB321745   Gene BCCIP, variant not shown              
DA653099   Gene BCCIP, variant not shown       capped      
DB326717 brain Gene BCCIP, variant not shown              
DA796024 brain Gene BCCIP, variant not shown       capped      
DB371432 ovary, tumor tissue Gene BCCIP, variant not shown              
DA812125 ovary, tumor tissue Gene BCCIP, variant not shown       capped      
DB050584 testis Gene BCCIP, variant not shown       capped      
? Gene Summary Gene on genome mRNA:.a, .b, .c, .d, .e, .f, .g, .h, .i, .j-u, .k-u, .l, .m-u, .n-u, .o-u Alternative mRNAs features, proteins, introns, exons, sequences Expression Tissue Function, regulation, related genes DCI